| Investigator & Role |
Grant Title |
Funding Source |
Duration |
| Elina Jerschow, M.D., M.S., principal investigator; Douglas G. Brownfield, Ph.D., co-principal investigator |
Staphylococcus Aureus and Eicosanoid Dysregulation as Drivers of Inflammation in Aspirin-Exacerbated Respiratory Disease |
National Institutes of Health — National Institute of Allergy and Infectious Diseases R21AI171306 |
07/05/2024-05/31/2026 |
| Elina Jerschow, M.D., M.S., principal investigator; Golda Hudes, M.D., co-principal investigator |
Effect of 16-Week Dupilumab Treatment on Sinonasal Respiratory Symptoms and Sense of Smell in Ethnically Diverse Patients With Chronic Rhinosinusitis and Nasal Polyposis |
Regeneron |
01/13/2022-05/01/2026 |
| Elina Jerschow, M.D., M.S., principal investigator; Douglas G. Brownfield, Ph.D., co-principal investigator; Kathryn A. Knoop, Ph.D., co-principal investigator; Erin K. O'Brien, M.D., co-principal investigator; Connie B. Chang, Ph.D., co-principal investigator |
Exotoxin-Producing Bacteria Drive Paradoxical Eicosanoid Profile in AERD |
Mayo Clinic Center for Clinical and Translational Science-Center for Biomedical Discovery pilot award |
01/01/2024-12/31/2024 |
| Elina Jerschow, M.D., M.S., co-principal investigator; Erin K. O'Brien, M.D., co-principal investigator |
Identifying Epitopes for Th2A Cells in Nasal Polyps of Patients With AERD |
Mayo Clinic Novel Therapeutics and Advanced Diagnostics Award |
08/01/2023-12/31/2024 |
| Elina Jerschow, M.D., M.S., principal investigator |
Th2A cells mediate outcomes of aspirin-exacerbated respiratory disease (AERD) |
National Institutes of Health — National Institute of Allergy and Infectious Diseases R21AI146804 |
09/03/2020-08/31/2023 |